Why 2020 Is the Time to Feel Better
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- How many people with migraine speak to a health professional?
- Why are so few people with migraine disease working with a health professional?
- When was migraine first described and what were some early treatments?
- What are the options for migraine treatment?
- What is a migraine treatment map?
- What factors can we control?
- What role is there for lifestyle management and education, and what are some examples?
- What are behavioral therapies for migraine?
- What emerging therapies are there in the behavioral treatment field?
- Which pharmaceutical treatments are commonly used?
- What are interventional approaches to migraine?
- What is neuromodulation, and what options are available?
- What is integrative medicine?
- What are some examples of complementary therapies?
- If you’ve given up, where do you find the motivation to keep trying?
- What does self-care really mean?
Interview Notes
Dawn C. Buse, PhD
Psychologist & Clinical Professor
Albert Einstein College of Medicine
Dawn C. Buse, PhD, is a clinical professor of neurology at Albert Einstein College of Medicine. She is a member of the board of directors of the Headache Cooperative of the Pacific, and a licensed psychologist. She has authored more than 200 scientific manuscripts and has won eight U.S. and international research awards and six professional awards for her work in the field of migraine.
She is a co-investigator on numerous U.S. and international studies, including the American Migraine Prevalence and Prevention (AMPP) study; the Chronic Migraine Epidemiology and Outcomes (CaMEO) study; the Migraine Signature Study (MSS); the International Burden of Migraine Study (IBMS); the Migraine in America Symptoms and Treatment (MAST) study; the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) study; and a recipient of the FDA-sponsored Migraine Clinical Outcome Assessment System (MiCOAS) grant, which is gathering patient input for the development of migraine clinical trial endpoints. She is an advocate for the well-being of patients and healthcare professionals.
Interviews from Dawn C. Buse, PhD
Brain-Related Comorbidities of Migraine
How Migraine Affects Our Mental Health
Staying Hopeful: Treatment Burnout in Chronic Disease
Cultivating Resilience and Strength Through Migraine
How Depression Affects Your Mood: Anxiety & Depression
Is Your Family Time Affected by Migraine?
Behavioral Approaches / Impact of Childhood Abuse
Purchase full access to the entire 2024 Summit to unlock:
- All expert interviews with separate audio (MP3) files & transcripts
- 30 extended, uncut interview editions with hours more expert footage
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Directory & Guidelines
- And much more!
Related Talks for: Day 9 (2020) MWS Onstage Presentations
Are You Really “Just Fine”?
William B. Young, MD
How Can You Stand Up Against Migraine?
Amaal J. Starling, MD, FAHS, FAAN
Migraine Is No Joke For This Comedian
Whitney Cummings
